AAAAAA

   
Results: 1-6 |
Results: 6
NEW AZA-DIPEPTIDE ANALOGS AS POTENT AND ORALLY ABSORBED HIV-1 PROTEASE INHIBITORS - CANDIDATES FOR CLINICAL DEVELOPMENT
Authors: BOLD G FASSLER A CAPRARO HG COZENS R KLIMKAIT T LAZDINS J MESTAN J PONCIONI B ROSEL J STOVER D TINTELNOTBLOMLEY M ACEMOGLU F BECK W BOSS E ESCHBACH M HURLIMANN T MASSO E ROUSSEL S UCCISTOLL K WYSS D LANG R
Citation: G. Bold et al., NEW AZA-DIPEPTIDE ANALOGS AS POTENT AND ORALLY ABSORBED HIV-1 PROTEASE INHIBITORS - CANDIDATES FOR CLINICAL DEVELOPMENT, Journal of medicinal chemistry, 41(18), 1998, pp. 3387-3401
SYNTHESIS OF POTENT AND ORALLY-ACTIVE HIV-PROTEASE INHIBITORS
Authors: CAPRARO HG BOLD G FASSLER A COZENS R KLIMKAIT T LAZDINS J PONCIONI B ROSEL JL STOVER D LANG M
Citation: Hg. Capraro et al., SYNTHESIS OF POTENT AND ORALLY-ACTIVE HIV-PROTEASE INHIBITORS, Archiv der pharmazie, 329(6), 1996, pp. 273-278
PROFILE OF CGP-61755 - A NOVEL AND POTENT HIV-1 PROTEASE INHIBITOR THAT SHOWS ENHANCED ANTI-HIV ACTIVITY WHEN COMBINED WITH OTHER ANTIRETROVIRAL AGENTS IN-VITRO
Authors: LAZDINS JK BOLD G CAPRARO HG COZENS R FASSLER A FLESCH G KLIMKAIT T LANG M MESTAN J PONCIONI B ROSEL J STOVER D TINTELNOTBLOMLEY M WALKER MR WOODSCOOK K
Citation: Jk. Lazdins et al., PROFILE OF CGP-61755 - A NOVEL AND POTENT HIV-1 PROTEASE INHIBITOR THAT SHOWS ENHANCED ANTI-HIV ACTIVITY WHEN COMBINED WITH OTHER ANTIRETROVIRAL AGENTS IN-VITRO, Schweizerische medizinische Wochenschrift, 126(43), 1996, pp. 1849-1851
AZA-PEPTIDE ANALOGS AS POTENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS WITH ORAL BIOAVAILABILITY
Authors: FASSLER A BOLD G CAPRARO HG COZENS R MESTAN J PONCIONI B ROSEL J TINTELNOTBLOMLEY M LANG M
Citation: A. Fassler et al., AZA-PEPTIDE ANALOGS AS POTENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS WITH ORAL BIOAVAILABILITY, Journal of medicinal chemistry, 39(16), 1996, pp. 3203-3216
PHARMACOKINETICS OF A NOVEL HIV-1 PROTEASE INHIBITOR INCORPORATED INTO BIODEGRADABLE OR ENTERIC NANOPARTICLES FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION TO MICE
Authors: LEROUX JC COZENS R ROESEL JL GALLI B KUBEL F DOELKER E GURNY R
Citation: Jc. Leroux et al., PHARMACOKINETICS OF A NOVEL HIV-1 PROTEASE INHIBITOR INCORPORATED INTO BIODEGRADABLE OR ENTERIC NANOPARTICLES FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION TO MICE, Journal of pharmaceutical sciences, 84(12), 1995, pp. 1387-1391
CGP-53437, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE WITH POTENT ANTIVIRAL ACTIVITY
Authors: ALTERI E BOLD G COZENS R FAESSLER A KLIMKAIT T LANG M LAZDINS J PONCIONI B ROESEL JL SCHNEIDER P WALKER M WOODSCOOK K
Citation: E. Alteri et al., CGP-53437, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE WITH POTENT ANTIVIRAL ACTIVITY, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2087-2092
Risultati: 1-6 |